Senscure Biotechnology Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 4

Senscure Biotechnology General Information

Description

Provider of surgical devices designed to innovate and improve minimally invasive surgery technology. The company's devices focuses on tumor treatment and offers series of products such as laparoscopic single port multi-channel access platform, pulmonary nodule localization needle, tumor cryoablation system and anti-gastroesophageal reflux system, enabling users to get complete medical equipment for surgeries.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 3, Block B, Number 777, Binhai 4th Road
  • Hangzhou Bay New District
  • Ningbo, Zhejiang 315336
  • China
+86 0574
Primary Industry
Surgical Devices
Corporate Office
  • Building 3, Block B, Number 777, Binhai 4th Road
  • Hangzhou Bay New District
  • Ningbo, Zhejiang 315336
  • China
+86 0574

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Senscure Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 24-May-2019 Completed Generating Revenue
1. Later Stage VC (Series A) 27-Mar-2018 Completed Generating Revenue
To view Senscure Biotechnology’s complete valuation and funding history, request access »

Senscure Biotechnology Patents

Senscure Biotechnology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026124668-A1 Liquid nitrogen cryoablation system and control method therefor Pending 12-Dec-2024
WO-2026082175-A1 Cryoablation system Pending 18-Oct-2024
WO-2026056904-A1 Spray cryoablation catheter, sealing device, and catheter Pending 10-Sep-2024
WO-2025153115-A1 Balloon catheter Pending 19-Jan-2024
WO-2024149191-A1 Ablation device for airway tissue, system and control method Inactive 09-Jan-2023
To view Senscure Biotechnology’s complete patent history, request access »

Senscure Biotechnology Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Proxima Capital Venture Capital Minority
Shengshan Asset Management Venture Capital Minority
Furong Capital Growth/Expansion Minority
YuanBio Venture Capital Venture Capital Minority
To view Senscure Biotechnology’s complete investors history, request access »

Senscure Biotechnology FAQs

  • When was Senscure Biotechnology founded?

    Senscure Biotechnology was founded in 2011.

  • Where is Senscure Biotechnology headquartered?

    Senscure Biotechnology is headquartered in Ningbo, China.

  • What industry is Senscure Biotechnology in?

    Senscure Biotechnology’s primary industry is Surgical Devices.

  • Is Senscure Biotechnology a private or public company?

    Senscure Biotechnology is a Private company.

  • What is Senscure Biotechnology’s current revenue?

    The current revenue for Senscure Biotechnology is .

  • How much funding has Senscure Biotechnology raised over time?

    Senscure Biotechnology has raised $9.5M.

  • Who are Senscure Biotechnology’s investors?

    Proxima Capital, Shengshan Asset Management, Furong Capital, and YuanBio Venture Capital have invested in Senscure Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process